Nasdaq smmt.

Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit …Cambridge, Massachusetts-based biotech Summit Therapeutics (NASDAQ:SMMT) jumped ~38% pre-market Tuesday after announcing a collaboration and license agreement with Hong Kong-listed biopharma Akeso ...Summit Therapeutics Inc. (NASDAQ:SMMT) is a biotechnology company that focuses on developing treatments to target infectious diseases. The firm is headquartered in Cambridge, Massachusetts.WebDec 4, 2023 · Bitdeer Technologies Holding Co (NASDAQ:BTDR)’s Major holders Insiders own 59.14% of the company shares, while shares held by institutions stand at 2.18% with a share float percentage of 5.33%. Investors are also buoyed by the number of investors in a company, with Bitdeer Technologies Holding Co having a total of 13 institutions that hold ... OXFORD, United Kingdom, Nov. 23, 2015 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...

Summit Therapeutics Inc. (NASDAQ:SMMT) insiders placed bullish bets worth US$62m in the last 12 months. (Simply Wall St.) Mar-17-22 04:14PM. Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2021. (GlobeNewswire) +7.93%.

Summit Therapeutics PLC (NASDAQ:SMMT)’s CEO Robert Duggan also bought a 376 million shares of the company during the same month at $1.05 per share. As of May 19, the stock is trading at $1.62.Find the latest press releases from Summit Therapeutics Inc. Common Stock (SMMT) at Nasdaq.com.

MENLO PARK, Calif., January 30, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit" or the "Company") today announced that the Company’s Board of Directors has set the record date for the ...WebSummit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call ...OXFORD, United Kingdom, Oct. 04, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...Find the latest news headlines from Summit Therapeutics Inc. Common Stock (SMMT) at Nasdaq.com.Lihat chart Summit Therapeutics Inc. live untuk melacak pergerakan harga sahamnya. Temukan prediksi pasar, berita finansial dan pasar dari SMMT.

Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After ...Web

Complete Summit Therapeutics Inc. stock information by Barron's. View real-time SMMT stock price and news, along with industry-best analysis.

Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit …BABA. 73.60. -1.71%. 19.59M. New. View today's Summit Therapeutics PLC stock price and latest SMMT news and analysis. Create real-time notifications to follow any changes in …Shares of Summit Therapeutics ( SMMT) were down more than 13% on Tuesday. The biotech company's shares have been trending downward since it released first-quarter earnings late last week. On top ...Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call ...Summit Therapeutics Inc.'s (NASDAQ:SMMT) CEO Robert Duggan is the most upbeat insider, and their holdings increased by 431% last week Read full article Simply Wall StSummit Therapeutics Inc. Common Stock (SMMT) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.

MENLO PARK, Calif.--(BUSINESS WIRE)-- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced that the Company’s Board of Directors has set the record date for the Company’s previously announced rights offering, which will be available to all holders of record of the Company’s common stock, …Oxford, UK, and Cambridge, MA, US, 3 October 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announced that it presented results from the Phase 2 clinical trial of ridinilazole in ...Summit Therapeutics Inc (NASDAQ:SMMT) shares are down by almost 13% year to date bringing their 12-month return to over 85%. As of this writing, Summit Therapeutics shares are trading at around $3.70 with a 52-week range of $0.66 to $5.78, giving the company a market capitalization of more than $835 million. PDS …WebCambridge, MA, June 01, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Ankur Dhingra has been appointed as Chief Financial Officer, effective immediately. “We are in a pivotal time for Team Summit as we seek to expand our portfolio of pipeline assets through potential collaborations and …Summit Therapeutics Inc. (NASDAQ:SMMT) is a biotechnology company that focuses on developing treatments to target infectious diseases. The firm is headquartered in Cambridge, Massachusetts.WebAs part of this collaboration deal, Summit Therapeutics paid $500 million upfront (financed via a rights offering) and could be on the hook for another $4.5 billion in future milestone payouts ($1 ...

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Summit Therapeutics (NASDAQ: SMMT ) announced during its Third Quarter 2023 Earnings and Update Call that it has started enrolling for the second Phase III clinical trial for ivonescimab, a potential treatment for non-small cell lung cancer. The company also introduced its new Chief Operating Officer, Manmeet Soni, who has made a $5 million …WebMay 3, 2023 · Nasdaq. 14,305.03 +78.81 ... Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have ... 3 de fev. de 2023 ... Summit Therapeutics (NASDAQ:SMMT) shares are plummeting over 40% on Friday morning. Gaucho Group Holdings (NASDAQ:VINO) stock is diving more ...Cambridge, MA, July 01, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (the “Company”) today announced that members of our scientific team will present breakthrough research ...WebCreate your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started. Outsmart the market with Smart Portfolio analytical tools powered …Dec 1, 2023 · See the latest Summit Therapeutics Inc Ordinary Shares stock price (SMMT:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Cambridge, MA, April 21, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that it has commenced its previously-announced rights offering of up to 14,312,977 shares of the Company’s ...WebBy way of example, Summit Therapeutics (NASDAQ:SMMT) has seen its share price rise 106% over the last year, delighting many shareholders. Having said that, unprofitable companies are risky because ...Summit Therapeutics Inc. Common Stock (SMMT) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.

OXFORD, United Kingdom, Nov. 23, 2015 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...

Cambridge, Massachusetts-based biotech Summit Therapeutics (NASDAQ:SMMT) jumped ~38% pre-market Tuesday after announcing a collaboration and license agreement with Hong Kong-listed biopharma Akeso ...

Summit Therapeutics Inc. Common Stock (SMMT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Based on analysts offering 12 month price targets for SMMT in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Summit Therapeutics Inc. (NASDAQ:SMMT) is a biotechnology company that focuses on developing treatments to target infectious diseases. The firm is headquartered in Cambridge, Massachusetts.WebCambridge, Massachusetts, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) is today displaying an important ePoster at IDWeek 2021.Stocks that have clustered insider purchases in March include The Charles Schwab Corporation (NYSE:SCHW), Keurig Dr Pepper Inc.(NASDAQ:KDP), and Summit Therapeutics PLC (NASDAQ:SMMT). 7. GuruFocusWeb2 de nov. de 2023 ... (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that Laura Chow, MD, has joined Summit Therapeutics as Senior Vice ...By way of example, Summit Therapeutics (NASDAQ:SMMT) has seen its share price rise 106% over the last year, delighting many shareholders. Having said that, unprofitable companies are risky because ...Cambridge, Massachusetts-based biotech Summit Therapeutics (NASDAQ:SMMT) jumped ~38% pre-market Tuesday after announcing a collaboration and license agreement with Hong Kong-listed biopharma Akeso ...26 de abr. de 2016 ... ... (NASDAQ: SMMT, AIM: SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy ('DMD') and ...The public float for SMMT is 111.77M and currently, short sellers hold a 8.48% ratio of that float. The average trading volume of SMMT on November 16, 2023 was 972.70K shares. SMMT) stock’s latest price update. The stock of Summit Therapeutics Inc (NASDAQ: SMMT) has increased by 0.51 when compared to last closing price of 1.97.Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Web

Menlo Park, CA, June 03, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) invites our shareholders and other interested parties to attend our Company’s Annual Shareholders’ Meeting, which will now be held virtually on Thursday, June 16, 2022, at 1:00 pm Eastern Time, one day later than previously planned. We are …WebCambridge, MA, April 21, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that it has commenced its previously-announced rights offering of up to 14,312,977 shares of the Company’s ...WebBABA. 73.60. -1.71%. 19.59M. New. View today's Summit Therapeutics PLC stock price and latest SMMT news and analysis. Create real-time notifications to follow any changes in …(NASDAQ: SMMT) Summit Therapeutics's 52-week high was $5.78, and its 52-week low was $0.75. It is currently -63.15% from its 52-week high and 184% from its 52- ...Instagram:https://instagram. app stock forecastnmrdnasdaq ambaonline banking with digital debit card The public float for SMMT is 111.75M, and currently, short sellers hold a 9.57% ratio of that floaft. The average trading volume of SMMT on November 08, 2023 was 1.02M shares. SMMT) stock’s latest price update. Summit Therapeutics Inc (NASDAQ: SMMT)’s stock price has plunge by -12.16relation to previous closing price of 2.18.OXFORD, United Kingdom, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) the drug discovery and development company advancing therapies for Duchenne muscular ... eem holdingsfiserve stock Dec 20, 2021 · Cambridge, MA, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced topline results for the Phase III Ri-CoDIFy study ... home loan broker course Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Cambridge, Massachusetts, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on ...SMMT | January 20, 2023. Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that we have completed the closing of our previously announced definitive agreement with Akeso Inc. (HKEX Code: 9926.HK, “Akeso”) to in-license its breakthrough bispecific antibody, ivonescimab.